| Analysis | Metabolite Name | Measured Value | Units | Treatment | Sample_description |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.2597 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.2597 | Normalized scale | Infected | secondary mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.2640 | Normalized scale | Infected | patial green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.3577 | Normalized scale | Infected | mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.3649 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.4316 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.4496 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.5528 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.5569 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.5700 | Normalized scale | Infected | secondary mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.5704 | Normalized scale | Infected | mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.6292 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.6407 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.6617 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.7522 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.7667 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.8248 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.8269 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.8557 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.8753 | Normalized scale | Infected | secondary mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.9113 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.9647 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.9714 | Normalized scale | Infected | complete green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 0.9725 | Normalized scale | Infected | patial green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.0000 | Normalized scale | Infected | complete green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.0286 | Normalized scale | Infected | secondary mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.0682 | Normalized scale | Infected | white chlorosis |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.1141 | Normalized scale | Infected | complete green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.1291 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.1514 | Normalized scale | Infected | patial green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.3571 | Normalized scale | Infected | mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.3704 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.5318 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.7018 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.7818 | Normalized scale | Infected | white chlorosis |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 1.9227 | Normalized scale | Infected | white chlorosis |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 2.1445 | Normalized scale | Infected | vein clearing |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 2.1459 | Normalized scale | Infected | patial green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 2.1802 | Normalized scale | Infected | white chlorosis |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 2.7840 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 3.0782 | Normalized scale | Infected | mosaic |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 3.0985 | Normalized scale | Infected | complete green recovery |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 3.1717 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 3.9318 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 5.9587 | Normalized scale | control | - |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 7.4780 | Normalized scale | Infected | vein clearing |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 8.4542 | Normalized scale | Infected | vein clearing |
| Reversed phase NEGATIVE ION MODE | 1-palmitoylglycerophosphate | 16.4568 | Normalized scale | Infected | vein clearing |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|